Recruiting Retinitis Pigmentosa Studies in Kansas City
About Retinitis Pigmentosa Clinical Trials in Kansas City
Retinitis pigmentosa (RP) is a group of inherited retinal diseases that cause progressive loss of photoreceptor cells in the retina, leading to vision loss. It typically begins with night blindness and progresses to tunnel vision. Gene therapy and retinal implants are areas of active research.
There are currently 2 retinitis pigmentosa clinical trials recruiting participants in Kansas City, KS. These studies are seeking a combined 754 participants. Research is being sponsored by Pfizer, Mitsubishi Tanabe Pharma America Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Retinitis Pigmentosa Clinical Trials in Kansas City — FAQ
Are there retinitis pigmentosa clinical trials in Kansas City?
Yes, there are 2 retinitis pigmentosa clinical trials currently recruiting in Kansas City, KS. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Kansas City?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Kansas City research site will contact you about next steps.
Are clinical trials in Kansas City free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Kansas City studies also compensate for your time and travel.
What retinitis pigmentosa treatments are being tested?
The 2 active trials in Kansas City are testing new therapies including novel drugs, biologics, and treatment approaches for retinitis pigmentosa.
Data updated July 17, 2026 from ClinicalTrials.gov